- Presentations
- 3
- Markets
- 1
Vizimpro is a brand of Dacomitinib marketed by Pfizer Laboratories, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Dacomitinib
- Brand owner
- Pfizer Laboratories
- Registered in
- United States
- Strengths and forms
- 15 mg tablet, 30 mg tablet, 45 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Vizimpro 15 mg tabletOral | Pfizer Laboratories | US FDA | Available on request |
| Vizimpro 30 mg tabletOral | Pfizer Laboratories | US FDA | Available on request |
| Vizimpro 45 mg tabletOral | Pfizer Laboratories | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Vizimpro
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.